Evidence map›Paper›PMID 40440409›Full record

ArticleACS applied materials & interfaces2025

Heterojunction of Silicon Nanowires and TiO

Jakub Szewczyk, Stefanos Chaitoglou, Igor Iatsunskyi, Ghulam Farid, Mariusz Jancelewicz, Roger Amade-Rovira, Enric Bertran-Serra, Emerson Coy

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jakub SzewczykNanoBioMedical Centre, Adam Mickiewicz University, Wszechnicy Piastowskiej 3, 61-614 Poznan, Poland.ORCID 0000-0001-9149-6731
Stefanos ChaitoglouDepartment of Applied Physics, University of Barcelona, C/Martí i Franquès, 1, 08028 Barcelona, Catalunya, Spain.
Igor IatsunskyiNanoBioMedical Centre, Adam Mickiewicz University, Wszechnicy Piastowskiej 3, 61-614 Poznan, Poland.
Ghulam FaridDepartment of Applied Physics, University of Barcelona, C/Martí i Franquès, 1, 08028 Barcelona, Catalunya, Spain.ORCID 0000-0002-1474-3927
Mariusz JancelewiczNanoBioMedical Centre, Adam Mickiewicz University, Wszechnicy Piastowskiej 3, 61-614 Poznan, Poland.
Roger Amade-RoviraDepartment of Applied Physics, University of Barcelona, C/Martí i Franquès, 1, 08028 Barcelona, Catalunya, Spain.
Enric Bertran-SerraDepartment of Applied Physics, University of Barcelona, C/Martí i Franquès, 1, 08028 Barcelona, Catalunya, Spain.ORCID 0000-0002-9694-3729
Emerson CoyNanoBioMedical Centre, Adam Mickiewicz University, Wszechnicy Piastowskiej 3, 61-614 Poznan, Poland.ORCID 0000-0002-4149-9720

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of photocatalytic hydrogen evolution depends on the availability of an efficient photocatalyst. This experiment aimed to create a type-II heterojunction between silicon nanowires and titanium dioxide bridged by a biomimetic polydopamine layer for efficient photocatalytic hydrogen production. This delivered adhesion, mechanical durability, outstanding wettability, and effective transfer of photogenerated charge carriers. Electron microscopy provided insight into the morphology and integration of the nanocoatings, while X-ray photoelectron spectroscopy confirmed the chemical structure of the nanocomposite before and after photocatalytic tests. These included voltammetric and impedance spectroscopy studies under UV-vis irradiation, which revealed a significant and stable photocurrent (up to 300 μA cm

Indexed as

band alignmentbioadhesionfunctionalizationheterointerfacenanocompositephotoreductionredox

Identifiers

PMID40440409
PMCPMC12163933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.